Nearly Half of Patients Seeking Vulvovaginal Disorder Care Report Negative Experiences
By Lori Solomon HealthDay Reporter
TUESDAY, May 13, 2025 -- Patients seeking care for vulvovaginal disorders report distress and gaslighting from past clinical experiences, according to a study published online May 8 in JAMA Network Open.
Chailee F. Moss, M.D., from the Centers for Vulvovaginal Disorders in Washington, D.C., and colleagues designed a patient-centered instrument and used it to conduct a survey of 447 patients treated at a vulvovaginal disorder referral clinic from August 2023 to February 2024 to assess patient experience.
The researchers found that a mean of 43.5 percent of patients reported that past practitioners were supportive, 26.6 percent were belittling, and 20.5 percent did not believe them. Roughly one in four patients (41.6 percent) were told they just needed to relax more, while 20.6 percent were advised to drink alcohol. Roughly half of patients (52.8 percent) considered ceasing care because their concerns were not addressed, while 20.6 percent were referred to psychiatry without medical treatment, 16.8 percent felt unsafe during a medical encounter, and 39.4 percent said they were made to feel crazy. Made to feel crazy was the most distressing surveyed behavior (rated at a mean of 7.39 of 10 on a numerical rating scale of distress). Qualitative themes included lack of clinician knowledge (247 quotations) and dismissive behaviors (211 quotations).
"There is an urgent need for education supporting a biopsychosocial, trauma-informed approach to vulvovaginal pain and continued development of validated instruments to quantify patient experiences," the authors write.
Several authors disclosed ties to the pharmaceutical and biotechnology industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-14 06:00
Read more

- Mirum’s Livmarli Now FDA Approved in Tablet Formulation
- Anemia In Pregnancy Increases Risk Of Heart Defects
- Teva and Alvotech Announce FDA Approval of Interchangeability for Selarsdi (ustekinumab-aekn) with Stelara (ustekinumab)
- FDA Approves Avmapki Fakzynja Co-Pack (avutometinib capsules/defactinib tablets) for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
- Trump Administration Ends CDC's Key Infection Control Committee
- More Kids Without Asthma Inhaler After Flovent Taken Off Market
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions